STRATA Skin Sciences, Inc. (SSKN) Current Deferred Revenue (2012 - 2025)

STRATA Skin Sciences has reported Current Deferred Revenue for 14 years, with the latest figure at $2.2 million in Q4 2025.

• Quarterly Current Deferred Revenue changed 0.31% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (changed 0.31% YoY) and the FY2025 annual result came in at $2.2 million, changed 0.31% from the prior year.
• Current Deferred Revenue declined to $2.2 million in Q4 2025 per SSKN's latest filing, from $2.6 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $3.8 million in Q3 2021 and troughed at $2.1 million in Q4 2023.
• A 5-year average of $2.6 million and a median of $2.4 million in 2023 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2021 and 2023: Current Deferred Revenue soared 132.84% in 2021, then slipped 25.12% in 2023.
• Over 5 years, Current Deferred Revenue stood at $3.3 million in 2021, then fell by 15.43% to $2.8 million in 2022, then retreated by 23.69% to $2.1 million in 2023, then rose by 5.71% to $2.2 million in 2024, then climbed by 0.31% to $2.2 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.2 million, $2.6 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.